Stock 8189 TIANJIN TEDA BIOMEDICAL ENGINEERING COMPANY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Tianjin TEDA Biomedical Engineering Company Limited

Equities

8189

CNE1000004H7

Market Closed - Hong Kong S.E.
Other stock markets
 09:08:07 05/07/2024 BST 		5-day change 1st Jan Change
0.069 HKD -9.21% Intraday chart for Tianjin TEDA Biomedical Engineering Company Limited -9.21% -22.47%
06-07 Tianjin Teda Biomedical Engineering Company Limited Appoints Mr. Tu Xiangzhen as the Independent Non-Executive Director CI
03-28 Tianjin TEDA Biomedical Engineering Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Tianjin Teda Biomedical Engineering Company Limited Appoints Mr. Tu Xiangzhen as the Independent Non-Executive Director
CI
Tianjin TEDA Biomedical Engineering Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Tianjin TEDA Biomedical Engineering Company Limited Announces Resignation of Mr. Li Xudong as Independent Non-Executive Director and Chairman of the Audit Committee
CI
An undisclosed buyer agreed to acquire an unknown stake in Shanghai Weidi Network Technology Company Limited from Tianjin TEDA Biomedical Engineering Company Limited
CI
Tianjin TEDA Biomedical Engineering Company Limited Announces Chief Executive Officer Changes
CI
Tianjin TEDA Biomedical Engineering Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Tianjin TEDA Biomedical Engineering Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Tianjin TEDA Biomedical Engineering Company Limited Announces Change of Principal Place of Business in Hong Kong
CI
Tianjin TEDA Biomedical Engineering Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Tianjin TEDA Biomedical Engineering Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Tianjin TEDA Biomedical Engineering Company Limited Announces Mr. Hao Zhihui Will Retire as an Executive Director
CI
Tianjin TEDA Biomedical Engineering Company Limited Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
CI
Tianjin Teda Biomedical Engineering Company Limited Announces Executive Changes
CI
Tianjin TEDA Biomedical Engineering Company Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
Tianjin TEDA Biomedical Engineering Company Limitedcompleted the acquisition of Shanghai Weidi Network Technology Company from three shareholders.
CI
Tianjin TEDA Biomedical Engineering Company Limited entered into the Equity Transfer Agreement to acquire Shanghai Weidi Network Technology Company from three shareholders for CNY12.8 million.
CI
Tianjin TEDA Biomedical Engineering Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Tianjin TEDA Biomedical Engineering Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Tianjin Teda Biomedical Engineering Company Limited Announces Delay in Publication and Despatch of Annual Report for the Year
CI
Tianjin TEDA Biomedical Engineering Company Limited Approves Appointment of Mr. Zhao Zhiyou as the Independent Supervisor
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 8189 Stock
  4. News Tianjin TEDA Biomedical Engineering Company Limited